Somatic Symptom Disorder With a Medical Condition: How Both Are Assessed
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Somatic symptom disorder (SSD) can be diagnosed in a person who has a medically established disease. A patient may simultaneously have rheumatoid arthritis, diabetes, an inflammatory bowel disease, heart disease, cancer, or another physical condition and experience a persistent, clinically excessive pattern of thoughts, anxiety, or behavior centered on distressing bodily symptoms. The medical illness remains real and deserves disease-specific treatment; the additional SSD assessment concerns how the symptoms are experienced, interpreted, and responded to over time. The American Psychiatric Association explicitly recognizes coexistence.
The central clinical question is therefore how to assess two potentially interacting aspects of health without allowing either diagnosis to replace the other. This guide explains the DSM-5-TR criteria, how to establish what the medical condition does and does not explain, which emotional and behavioral responses warrant careful evaluation, how clinicians manage uncertainty, when investigations should be renewed, and how coordinated treatment protects physical and psychological health.
Can somatic symptom disorder occur when a physical disease has been diagnosed?
Yes. Under DSM-5-TR, an identifiable medical explanation for a symptom is neither required nor disqualifying. A person may have objectively documented disease and meet criteria for SSD when distressing symptoms are accompanied by the characteristic excessive symptom-related thoughts, feelings, or behaviors and the full clinical criteria are satisfied. Equally, having a disease, severe pain, substantial functional loss, a long medical history, or understandable fear of complications does not, by itself, establish SSD. See the DSM-5-TR classification chapter.
Imagine two people with the same medical diagnosis. Their pain, daily limitations, access to treatment, financial circumstances, and uncertainty may differ greatly. Clinicians must evaluate these circumstances before interpreting a person's responses as excessive. A medically justified search for treatment, repeated clinical contact caused by unresolved symptoms, careful monitoring prescribed by specialists, or concern after dangerous symptoms is ordinarily compatible with appropriate self-protection. SSD requires a separate and supported account of disproportionate symptom-related cognition, distress, or time-and-energy expenditure in the overall context.
What SSD means in DSM-5-TR
Criterion A: distressing somatic symptoms
There must be one or more physical symptoms that cause significant distress or disruption in daily life. The symptoms may include pain, fatigue, gastrointestinal complaints, cardiopulmonary sensations, dizziness, or combinations of symptoms. They are experienced as real. The disorder's definition does not require a particular organ system or the absence of findings in medical tests. Physical suffering and disability deserve assessment irrespective of whether SSD is ultimately diagnosed. See APA's patient-facing clinical explanation.
Criterion B: excessive symptom-related thoughts, feelings, or behaviors
At least one of three patterns is required: persistent and disproportionate thoughts about the seriousness of symptoms; persistently high anxiety about symptoms or health; or excessive time and energy devoted to those symptoms or health concerns. A clinician assesses persistence, intensity, consequences, the known medical risks, and the patient's actual circumstances. This is a qualitative clinical judgment informed by evidence and discussion, not a reaction to a single behavior. The three manifestations are alternatives within this criterion; a person need not exhibit all of them. The DSM-5-TR remains the source of the formal classification.
A person with poorly controlled asthma who checks breathing when instructed, a patient with diabetes who measures glucose as prescribed, or an oncology patient urgently reporting a new symptom is responding to a medical need. Clinicians should examine whether a response goes beyond an individualized, medically justified approach before assigning any diagnostic significance. This matters especially when the disease carries genuine risks of sudden deterioration or when the patient's symptoms have previously been minimized.
Criterion C: persistent symptomatic state
The symptomatic state is persistent, typically longer than six months, even if an individual symptom is not present continuously. Duration alone is insufficient: the relevant symptom burden and cognitive-affective-behavioral pattern must be considered together. DSM-5-TR also includes specifiers related to predominant pain, persistent course, and current severity; their application is a clinician's task. A short period of fear after an acute diagnosis cannot automatically be recast as a chronic psychiatric disorder.
A diagnosis is not a verdict about the cause of the physical symptoms
The word 'somatic' means bodily. SSD names a clinical pattern of distress and response surrounding bodily symptoms, not a laboratory finding about the biological origin of those symptoms. Psychological processes may influence symptom attention, expectations, threat appraisal, activity, and coping, while the symptoms may also reflect tissue injury, inflammation, infection, neurological disease, endocrine dysregulation, medication effects, or other biological processes. Contemporary reviews describe persistent symptoms as potentially arising through interacting biological, psychological, and social processes, with the strength of each explanation varying by person and condition. See Löwe and colleagues, The Lancet (2024)).
Why assessing both conditions requires two parallel clinical questions
Question one: What is happening medically?
Clinicians establish the medical diagnosis or diagnoses, current disease activity, probable mechanisms of the symptoms, response to treatment, comorbid physical conditions, adverse effects, and changes over time. A previously established illness is not a permanent explanation for every new complaint. A patient with arthritis can develop a separate neuropathy; a person with a known gastrointestinal disorder can develop a new infection; and medication toxicity can emerge after years of apparently stable treatment. Evaluation must remain proportionate to the present clinical picture.
The medical assessment commonly includes a detailed history, a focused examination and investigations chosen for a specific differential. It may include laboratory tests, imaging, physiological monitoring, or referral when indicated. The purpose is to evaluate clinically meaningful possibilities rather than repeatedly test everything. Guidelines and reviews emphasize sustained medical attention and coordinated care while avoiding unnecessary investigations that expose patients to harms without resolving uncertainty. Löwe et al. (2024)).
Question two: How is the person responding to the symptoms?
Clinicians also explore what the symptoms mean to the patient, which outcomes they fear, how much time goes to monitoring or researching them, and whether reassurance temporarily relieves concern before anxiety returns. They ask about activity restriction, medical avoidance, repeated emergency use, relationship and work effects, sleep, and how previous care shaped trust. Importantly, these behaviors are interpreted alongside disease severity, care accessibility, trauma histories if voluntarily relevant, past diagnostic errors, cultural context, and concrete threats to health. A person may be highly distressed without having a disproportionate response.
Assessment should produce a coherent account of both clinical dimensions. If symptom-focused anxiety is judged excessive and persistent, the clinician should explain which features support that conclusion and why those features exceed reasonable concern given the medical facts. Otherwise, the diagnosis becomes circular: high symptoms supposedly prove abnormal concern, and the abnormal concern supposedly proves SSD. In sound clinical practice, each conclusion has its own supporting evidence.
The two clinical formulations may change independently
Medical disease can improve while anxiety and avoidance persist; symptom-focused distress can diminish while pain or disease activity continues. A person can also undergo new physical deterioration after an SSD diagnosis has been established. Follow-up therefore tracks medical outcomes and symptom-related distress separately, rather than assuming improvement in one domain settles the other. This makes care safer and provides a more meaningful measure of treatment benefit.
A step-by-step integrated assessment
1. Establish the timeline and create a symptom map
A clinical interview reconstructs the order in which symptoms, diagnoses, treatments, complications, and changes in daily function appeared. The clinician records current symptoms and patterns: location, character, severity, duration, triggers, relieving factors, functional impact, and changes from baseline. For diseases with episodic exacerbations, symptom diaries or prescribed monitoring may help reveal medically important patterns. The patient's account, prior records, and specialist findings are integrated rather than treated as competing stories.
2. Review the medical diagnosis and adequacy of treatment
The team reviews how the physical diagnosis was established, which manifestations it is known to cause, whether objective evidence suggests activity or remission, and whether treatment has been accessible and sufficient. It reviews medication adherence without blame, benefits, adverse effects, sleep, nutrition, and other relevant medical factors. It also considers overlapping physical conditions and whether a symptom reflects a treatment complication. A psychiatric label must not substitute for appropriate testing, referral, or disease management.
3. Screen for urgent or evolving clinical problems
The current symptom pattern is compared with prior examinations. Newly developing neurological deficits, severe or rapidly worsening pain, significant breathing difficulty, acute chest pain, major bleeding, fainting, possible severe infection, and other red flags call for prompt medical assessment according to their clinical urgency. Sudden one-sided weakness, facial droop or speech difficulty requires emergency stroke assessment; severe chest pain or acute breathing difficulty also needs emergency care. Having an SSD diagnosis should never reduce the urgency of evaluating a genuine emergency.
4. Ask specific, nonjudgmental questions about concern and behavior
Useful questions include: 'What worries you most about this symptom?', 'What advice have specialists given you about monitoring?', 'What happens when you receive reassuring findings?', 'How much time does symptom checking take?', 'Which activities have you stopped, and why?', and 'Has your health care experience changed how safe you feel?' These questions distinguish proportionate vigilance from persistent health-threat preoccupation. Clinicians can also ask what the patient feels the current medical diagnosis explains and which symptoms remain unclear.
5. Assess functioning and broader mental health
Clinicians ask about school or work participation, home responsibilities, relationships, physical activity, sleep, and quality of life. They evaluate depression, anxiety, trauma-related symptoms when relevant, substance effects, and suicidal thinking when clinically indicated. Coexisting mental health symptoms can intensify disability and require their own treatment. Screening questionnaires can quantify burden, but a positive questionnaire result is not equivalent to a disorder. Life limitations should also be measured against actual medical disability and socioeconomic obstacles.
6. Formulate which findings support which diagnosis
A useful clinical formulation identifies established physical diagnoses; currently supported medical differentials; symptom-related anxiety, interpretations, and behaviors; practical barriers; and the evidence for or against SSD criteria. The team may conclude that SSD is present, that symptom distress is proportionate to severe illness, that another mental health condition better fits, or that further observation is needed. An assessment can be complete enough to begin supportive treatment without forcing premature diagnostic certainty.
7. Agree on medical follow-up and reconsideration thresholds
A written care plan clarifies which clinician coordinates care, how routine reviews work, which signs should trigger earlier reassessment, what tests or specialist referrals are indicated, and how to communicate new changes. Planned visits allow clinicians to watch illness activity and address distress without converting every new symptom into either a medical emergency or a psychiatric explanation. For children and adolescents, the Canadian Paediatric Society recommends family-centered communication, coordinated services, and ongoing monitoring of symptom evolution.
When does fear about a real medical condition become clinically excessive?
There is no universal amount of worry that establishes SSD. The clinical context matters. Fear after a cancer diagnosis, distress while awaiting a biopsy, vigilance after an unexpected medical crisis, or repeated requests for care following prior errors may be understandable. Behavioral intensity also depends on recommended self-monitoring, disease unpredictability, availability of effective treatment, caregiving responsibilities, and whether medical advice has been consistent. Clinicians judge disproportionality through sustained patterns and impairment, rather than through personal expectations about how an ideal patient should behave.
Features that may justify closer assessment include symptom-related thoughts that remain intrusive despite clear, consistent medical explanations; repeated checking far beyond a clinician-agreed monitoring plan; persistently high anxiety that dominates the day; or avoidance that greatly exceeds the medically necessary restrictions and progressively reduces functioning. Even here, clinical reasoning must account for genuinely missed diagnoses, fluctuating disease activity, diagnostic uncertainty and personal circumstances. These patterns are evidence to assess, not automatic diagnostic proof.
A critical distinction concerns functional consequences. Someone with advanced heart failure may be unable to work because of physical limitations; disability itself says nothing about SSD. A different person may avoid permitted movement because they believe every harmless sensation signals catastrophic injury. That avoidance could become a legitimate therapeutic target, but the clinician should first verify which activities are medically safe and whether the patient has clear, trustworthy guidance.
What if symptoms seem more severe than tests or disease activity suggest?
Disease measures and personal suffering capture different aspects of illness. Pain intensity does not map neatly onto a single imaging finding; fatigue, cognitive difficulty, and autonomic symptoms can persist after an acute disease marker normalizes; symptoms may fluctuate between visits. The discrepancy deserves further reasoning about pain processing, coexisting illness, medication effects, sleep and mood, and the sensitivity of the available tests. It does not itself indicate fabrication, SSD, or a psychological cause. The Lancet review of persistent physical symptoms) details the multiple mechanisms that may sustain physical complaints.
Consider a person with a documented inflammatory disease whose laboratory values have improved. Persistent pain could reflect residual inflammation, nerve injury, altered pain processing, a second condition, or several contributors. An SSD diagnosis additionally requires the DSM pattern of disproportionate symptom-related thoughts, feelings, or behaviors and longitudinal clinical assessment. The accurate response is to examine each plausible contributor and tailor care, rather than use a normal test result to settle a complex clinical question.
SSD compared with other conditions that may coexist with medical illness
Illness anxiety disorder and ordinary health anxiety
Illness anxiety disorder (IAD) involves a marked preoccupation with having or acquiring serious illness, generally with absent or only mild somatic symptoms. SSD centers on one or more distressing or disruptive symptoms together with the specified excessive symptom-related response. A person with serious medical illness may experience understandable health anxiety without either disorder. Determining whether fear is excessive requires attention to the actual disease and its prognosis. The diagnostic differences are detailed in the APA DSM-5-TR chapter.
Psychological factors affecting other medical conditions
DSM-5-TR also recognizes psychological factors affecting other medical conditions. Here, a medical condition is present and psychological or behavioral factors adversely affect its clinical course, treatment, risks or management. In SSD, diagnostic attention centers on excessive cognitions, emotions, or behaviors related to distressing physical symptoms. They can intersect but are not interchangeable; each diagnosis needs evidence for its distinct defining features. For example, difficulty following treatment due to depression or other psychological factors may require evaluation of the former category, whereas marked disproportionate symptom-focused concern may invite an SSD assessment. Classification must be applied carefully to the actual patient.
Anxiety disorders, panic and obsessive-compulsive disorder
Generalized anxiety may involve many subjects besides health; panic attacks bring episodic surges of fear and bodily arousal; and OCD involves obsessions and compulsions that can include intense monitoring of bodily processes. Similar checking behavior can serve different psychological functions and have different treatment implications. The Hub's published guide to somatic OCD covers body-focused obsessions and monitoring within the separate OCD framework. Diagnosis depends on the full symptom picture.
Depression, adjustment responses and trauma-related disorders
Physical illness can precipitate grief, loss of independence, depression, or stress responses. These states may coexist with SSD but should also be recognized on their own terms. Trauma exposure is one possible correlate of symptom burden, not a diagnostic prerequisite and not proof of an individual causal pathway. A 2024 systematic review of psychological risk factors identified associations with anxiety, depression and other factors while emphasizing major evidence gaps, including limited longitudinal research.
Functional neurological disorder and functional somatic syndromes
Functional neurological disorder (FND) is assessed through a neurological history and positive findings of altered motor or sensory function, with subtype-appropriate investigation. It is not inferred merely because scans are normal. Functional seizures, functional weakness and movement symptoms have specialized diagnostic pathways. Fibromyalgia, irritable bowel syndrome, post-infectious conditions and other physical symptom syndromes also have their own medical frameworks. A person may meet criteria for more than one condition; none of these labels automatically establishes SSD.
ICD-11 bodily distress disorder
ICD-11 bodily distress disorder (BDD) and DSM-5-TR SSD overlap conceptually, but their definitions, specified duration and clinical emphases are not identical. ICD-11 emphasizes sustained bodily symptoms associated with excessive attention; when an established medical condition contributes, its clinical requirements call for attention clearly excessive relative to the condition's nature and severity. Population research comparing these constructs confirms that they should not be treated as exact synonyms. Consult the WHO's ICD-11 clinical diagnostic guidance and the 2025 comparative epidemiological study.
Factitious disorder and malingering
Intentional falsification is a separate, high-stakes question. Severe distress, repeated requests for testing, discrepancies between tests and symptoms, or coexisting psychiatric illness do not demonstrate deception. Factitious disorder and malingering have distinct intentionality and contextual requirements that cannot be determined from a patient description or a simple symptom checklist. SSD assumes neither deliberate symptom production nor an external incentive. Concerns about safety or misleading records require professional evaluation, careful documentation and appropriate safeguarding.
How physical disease and symptom-related distress can influence one another
Research supports a multifactorial account of persistent physical symptoms. Inflammation, tissue injury, hormonal and autonomic changes, central nervous system processing, prior experiences, expectations, attention, learning, sleep, and emotional state may contribute differently across conditions. A disease episode can increase vigilance to bodily signals; worry may disturb sleep and intensify attention; reduced activity may lead to deconditioning; and repeated uncertainty may erode trust. These are plausible interacting pathways that clinicians can explore without asserting that psychology produced the original medical disease. Löwe et al., 2024).
Threat-related expectations and attentional focus may influence symptom perception, but the explanatory models of predictive processing, interoception and sensitization are not universal diagnostic tests. Physiological mechanisms and psychological interpretations must be distinguished from established individual causation. Correlation between anxiety and symptom severity can reflect effects in either direction, shared vulnerabilities, medical disease severity, or combinations of influences. The systematic review of SSD psychological risk factors cautions that longitudinal evidence remains limited.
Medical systems also affect illness behavior. Long delays, contradictory specialist advice, rushed explanations, discrimination, and past missed diagnoses can reasonably heighten health-related concern. Effective SSD care therefore includes attention to clinician communication and care coordination, not merely instructions for a patient to worry less. The person and medical team should reach an explicit, revisable explanation of symptoms and management.
Treatment when both SSD and a physical medical condition are present
Continue evidence-based treatment of the medical disease
Treatment begins with appropriate disease management: indicated medication, procedures, specialist monitoring, prevention, symptom relief and rehabilitation. SSD psychotherapy cannot replace insulin, anticoagulation, cancer treatment, anti-inflammatory therapy, or other prescribed disease-specific care. Physical symptoms must retain access to medical evaluation when clinically warranted. When a person struggles with treatment adherence or competing recommendations, the team works through barriers rather than presuming a psychiatric explanation.
Collaborative, longitudinal primary and specialty care
One clinician or coordinated team should maintain a longitudinal overview, including medical diagnoses, current medicines, pending investigations, agreed monitoring, and mental health care. Planned follow-up can reduce conflicting advice and create predictable access for new concerns. Specialist clinicians should continue to own questions involving their respective diseases; psychological clinicians can address symptom-related fear and behavioral patterns. An integrated service model developed through clinician and patient stakeholder work emphasizes common explanations and coordinated care pathways. Evidence-informed principles in The Lancet).
Cognitive behavioral therapy targeted to symptom-related responses
Cognitive behavioral therapy (CBT) can address catastrophic interpretations, checking and reassurance cycles, avoidance, activity pacing, sleep habits and valued-function goals. For someone with established medical disease, treatment plans must use accurate, individualized medical safety boundaries. Exposure exercises or activity changes are inappropriate if they contradict disease-specific precautions. Therapy is most useful when it addresses patterns that aggravate distress and disability while affirming physical limitations and maintaining medical care.
A 2025 network meta-analysis of 74 trials involving 8,277 participants reported benefits of CBT and acceptance- or mindfulness-based treatments for bodily distress, while noting limitations in comparative evidence. Many included studies used broader somatoform or functional-symptom categories rather than people with DSM-5-TR SSD and a specific diagnosed physical illness. Therefore, these estimates support the general relevance of psychological interventions but cannot be translated into a reliable individualized response rate for this precise dual-diagnosis population. Earlier Cochrane evidence similarly supported possible symptom improvements but rated parts of the evidence low quality.
Acceptance, mindfulness and function-oriented approaches
Acceptance-based strategies can support functioning when symptoms fluctuate or full relief is uncertain. The therapeutic goal may include less exhausting monitoring, greater flexibility, resumption of medically appropriate activities, and improved relationships and participation. Mindfulness should be adapted when body-focused attention increases distress; it is one option among several, not a universally appropriate prescription. The 2025 network meta-analysis addressed these interventions in varied bodily-distress populations, with considerable between-study differences.
Medication decisions
There is no single medication that proves or cures SSD. Pharmacological treatment may be indicated for the underlying medical condition, a distinct depressive or anxiety disorder, sleep symptoms, or other clinically defined targets. Prescribing must account for drug interactions, existing disease and adverse-effect risks. A Cochrane review of pharmacological interventions found low or very low certainty for many older somatoform-disorder medication comparisons and limited long-term data. These findings cannot establish that a medicine is beneficial for every patient with both SSD and physical disease.
Physical rehabilitation and symptom-oriented support
Physiotherapy, occupational therapy, graded return to selected activities, pain management or other rehabilitative care may be appropriate according to the underlying illness and functional impairments. The plan should recognize actual physiological limits, post-exertional symptom patterns where relevant, fall risk, and access needs. Applying a generic 'push through the symptoms' approach to complex illness can cause harm. Rehabilitation is jointly defined with the medical team and adjusted to the person's course of disease, tolerance, and personal goals.
Risks of dismissing medical disease after an SSD diagnosis
Diagnostic overshadowing occurs when one established label dominates interpretation of later complaints. An SSD diagnosis can become unsafe if it is used to explain acute changes, postpone needed examination, refuse indicated treatment, or discount objective findings. The safeguard is a plan for reassessment that takes a fresh history when symptoms materially change. New findings should update the diagnosis, including recognition of newly emerging illnesses and treatment complications.
Conversely, endlessly repeating low-yield investigations without a clear clinical indication can also cause harm through false positives, incidental findings, invasive procedures, radiation exposure where relevant, financial cost, and heightened uncertainty. The safe standard is medically justified investigation paired with thoughtful communication, not either unrestricted testing or automatic test refusal. Follow-up plans should clarify both the boundaries of routine reassurance and the criteria for urgent or targeted reassessment.
Special considerations in chronic and serious medical illness
People with autoimmune disease, chronic infections, neurological disorders, cancers, and other serious illnesses may face intermittent exacerbations, uncertain prognosis, intensive self-monitoring and clinically necessary medical contact. The threshold for declaring a behavior excessive must account for these realities. Disease-related uncertainty may be irreducible; some worry may remain appropriate even after careful review. Clinicians should explain the difference between risk-aware action and a pattern of worry that no longer improves decision-making or functioning.
Pain and fatigue deserve careful medical and rehabilitation assessment, including medication review and appropriate condition-specific evaluation. SSD can occur alongside such symptoms, but the diagnosis cannot stand in for determining the source of a disabling symptom or for calculating disability, accommodations, and treatment eligibility. Health systems should not use SSD labeling to deny legitimate disability supports.
Children and adolescents with medical illness and somatic symptom concerns
Developmental stage changes how young people describe symptoms and understand illness. Parents and schools may be monitoring real medical risks, and family behaviors can either support flexible functioning or unintentionally magnify vigilance. Clinical assessment should hear the young person's perspective, consider caregiving patterns without blaming family members, review actual illness activity, and understand school attendance, friendships, sleep, and developmental expectations. The Canadian Paediatric Society's 2024 guidance emphasizes validation, coordinated medical and psychological support, appropriate investigations, school reintegration, and continuing monitoring.
For a child with an established medical condition, clinicians should coordinate with the relevant pediatric specialist before changing monitoring or activity limits. School accommodations may be needed even when symptom-focused distress is being treated. A young person's fear should be interpreted in light of previous hospitalizations, procedures, communication style and family context. Treatment can begin with distress reduction and functional support while the medical team continues to evaluate evolving symptoms.
What should a patient expect from a high-quality assessment?
A high-quality consultation leaves the person with a clear explanation of what physical disease is established, what remains uncertain, why any SSD criteria appear relevant, how clinical findings were interpreted, and what follow-up will occur. The patient should be able to ask which new symptoms merit immediate medical attention and which concerns are best addressed during planned review. The explanation should specify that symptoms are real, that medical disease and SSD can coexist, and that care can address both domains concurrently.
Patients may find it helpful to bring a brief symptom timeline, medication and diagnosis list, important test results, a record of function changes, and their main unanswered questions. A structured summary can improve communication across specialists while limiting repetitive storytelling. Patients can ask for a second medical opinion when important clinical questions remain unresolved; coordinated follow-up is compatible with legitimate reconsideration of diagnosis.
Questions to ask your care team
Useful questions include: 'Which symptoms are explained by my documented disease, and which still need evaluation?' 'Which particular observations suggest an excessive symptom-related response rather than justified vigilance?' 'Are my current monitoring habits medically recommended?' 'Which changes would trigger new tests or urgent assessment?' 'Who coordinates my specialty and psychological care?' 'How will we measure improvements in medical status, distress, and day-to-day function separately?' A clear answer to these questions supports shared decision-making.
Prognosis and realistic outcomes
Outcomes depend on the underlying medical illness, duration and severity of symptom-related distress, access to consistent care, comorbid mental health conditions, disability, and social support. Some patients improve substantially with clearer diagnostic explanations, tailored psychotherapy and coordinated treatment. Others have relapsing distress or ongoing physical disability, even when their relationship to symptoms changes. Improvement should be measured across several domains, including medical disease activity, function, anxiety, health behaviors, participation and quality of life.
Evidence regarding psychological treatments for broadly defined bodily distress is stronger than evidence tailored specifically to SSD superimposed on well-characterized chronic physical disease. Studies often combine different diagnostic systems, ages, illness populations and symptom measures. The 2025 network meta-analysis supports treatment options, but does not settle which intervention works best for each medical comorbidity or predict long-term outcomes with precision. This remains a substantive research gap.
Frequently asked questions
Can someone have diabetes, arthritis, or cancer and somatic symptom disorder at the same time?
Yes. DSM-5-TR permits SSD in the presence of a diagnosed medical condition. Clinicians must still establish that the additional symptom-related thought, anxiety, or behavior pattern fulfills SSD criteria and cannot be better understood as proportionate to the particular person's illness and circumstances. Medical treatment continues.
Does an SSD diagnosis mean the medical disease was exaggerated or imagined?
No. The medical condition retains its own diagnostic status. SSD does not establish that physical symptoms are fabricated, that a medical diagnosis is invalid, or that all symptom mechanisms are psychological. The person deserves appropriate medical examination and symptom relief.
Can a severe illness cause high health anxiety without SSD?
Yes. A dangerous, unpredictable or newly diagnosed illness can reasonably cause substantial anxiety. The clinical distinction depends on persistence, disproportionality and the full diagnostic picture, including accurate assessment of genuine risks, prior experiences and access to care.
Should doctors stop testing once SSD is diagnosed?
No general rule supports stopping all medical investigations. Testing should follow current clinical indications, new findings, changes in symptoms and the established illness. Repeating unchanged tests without a clinical question may be unhelpful, but new red flags require fresh assessment.
Can treatment focus on anxiety while doctors still treat a physical disease?
Yes. Symptom-focused CBT or another appropriate intervention can proceed alongside disease-specific medication, specialist visits and rehabilitation. Psychological treatment can improve coping and function even when biological symptoms remain.
What is the difference between SSD and psychological factors affecting another medical condition?
SSD emphasizes distressing physical symptoms accompanied by excessive symptom-related thoughts, feelings or behaviors. Psychological factors affecting another medical condition emphasizes psychological or behavioral influences that adversely affect the medical condition's course or management. A clinician examines which criteria are supported, rather than choosing by the mere presence of medical illness.
Does having medically unexplained symptoms establish SSD?
No. The absence of a clear medical explanation is neither sufficient nor required for SSD. Appropriate medical assessment and the DSM symptom-related behavioral and psychological criteria are necessary for the diagnosis.
Is ICD-11 bodily distress disorder the same diagnosis?
They overlap in recognizing persistent bodily symptoms and excessive related attention or responses, but ICD-11 bodily distress disorder and DSM-5-TR SSD have distinct clinical descriptions and duration requirements. Clinical records should identify the actual classification system used.
Can doctors distinguish SSD from anxiety, OCD or depression in someone with medical illness?
A comprehensive interview examines the primary object of concern, symptom patterns, obsessions or compulsions, mood features, duration, functional effects, and responses to illness. Several conditions may coexist, so differential diagnosis is more useful than assuming a single explanation.
When should someone seek immediate care?
Sudden neurological changes, acute chest pain, severe breathing difficulty, major bleeding, a serious new seizure-like event or other potentially life-threatening symptoms require urgent local medical evaluation. A previous SSD diagnosis does not lower the importance of such warning signs.
Related Articles
For the broader relationship between personality-related distress and bodily reporting, see Neuroticism and Somatic Symptoms. For a clinically different pattern centered on obsessions and monitoring, see Somatic OCD. These pages have distinct canonical owners; this article addresses medical-illness coexistence and the dual assessment of SSD.
References
American Psychiatric Association. (2022). Somatic Symptom and Related Disorders. In Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). https://doi.org/10.1176/appi.books.9780890425787.x09_Somatic_Symptom_and_Related_Disorders
American Psychiatric Association. What Is Somatic Symptom Disorder? https://www.psychiatry.org/patients-families/somatic-symptom-disorder/what-is-somatic-symptom-disorder
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014). Pharmacological interventions for somatoform disorders in adults. Cochrane Database of Systematic Reviews, CD010628. https://doi.org/10.1002/14651858.CD010628.pub2
Löwe, B., Toussaint, A., Rosmalen, J. G. M., Huang, W.-L., Burton, C., Weigel, A., Levenson, J. L., & Henningsen, P. (2024). Persistent physical symptoms: Definition, genesis, and management. The Lancet, 403, 2649–2662. https://doi.org/10.1016/S0140-6736(24)00623-8)
Maas genannt Bermpohl, F., & Martin, A. (2025). Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress: A network meta-analysis. Psychotherapy and Psychosomatics, 94, 207–224. https://doi.org/10.1159/000544825
Saunders, N. R., Kawamura, A., MacLeod, O., Nieuwesteeg, A., & De Souza, C. (2024). Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers. Canadian Paediatric Society. https://cps.ca/en/documents/position/somatic-symptom-and-related-disorders
Smakowski, A., Hüsing, P., Völcker, S., Löwe, B., Rosmalen, J. G. M., Shedden-Mora, M., & Toussaint, A. (2024). Psychological risk factors of somatic symptom disorder: A systematic review and meta-analysis. Journal of Psychosomatic Research, 181, 111608. https://doi.org/10.1016/j.jpsychores.2024.111608
van Dessel, N., den Boeft, M., van der Wouden, J. C., et al. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews, CD011142. https://doi.org/10.1002/14651858.CD011142.pub2
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. https://www.who.int/publications/i/item/9789240077263
World Mental Health Survey Initiative investigators. (2025). The epidemiology of ICD-11 bodily distress disorder and DSM-5 somatic symptom disorder in new large-scale population surveys. World Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC12434350/